Xygrel 60mg Tablet contains Ticagrelor, a potent oral antiplatelet agent used to reduce the risk of thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) or a history of myocardial infarction. Ticagrelor acts as a reversible antagonist of the P2Y12 receptor on platelets, thereby inhibiting ADP-mediated platelet aggregation and preventing thrombus formation. This mechanism helps in reducing the incidence of cardiovascular death, myocardial infarction, and stroke. Xygrel is typically prescribed alongside low-dose aspirin for optimal efficacy in patients with unstable angina, non-ST elevation myocardial infarction (NSTEMI), or ST elevation myocardial infarction (STEMI). The recommended dosage is 60mg administered orally twice daily, with or without food, as directed by a healthcare professional. Caution is advised in patients with a history of bleeding disorders, hepatic impairment, or those undergoing surgery, as Ticagrelor may increase bleeding risk. Common adverse effects include dyspnea, bleeding, and bradyarrhythmias. Regular monitoring and adherence to prescribed dosage are essential to maximize therapeutic benefits while minimizing risks. Xygrel should be used under medical supervision, and patients should report any unusual bleeding or allergic reactions promptly.